There is substantial evidence suggesting that AMPK is dysregulated in animals and humans with T2D, and that AMPK activation (physiological or pharmacological or hormonal) could improve insulin sensitivity (Coughlan et al., 2014). Here, INS is linked to type 2 diabetes mellitus.